Study of efficacy and safety of buparlisib (BKM120) plus paclitaxel versus placebo plus paclitaxel in recurrent or metastatic head and neck cancer previously pre-treated with a platinum therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Phase II Study of efficacy and safety of buparlisib (BKM120) plus paclitaxel versus placebo plus paclitaxel in recurrent or metastatic Head and Neck cancer previously pre-treated with a platinum therapy.The primary endpoint was PFS and the key secondary endpoint was Overall Survival.
Epistemonikos ID: aebe9c54322b6172dd288af1f800dbff9ee853b3
First added on: May 11, 2024